1. Home
  2. RVNC
  3. RVNC News

Latest Revance Therapeutics Inc. (RVNC) News on January 5, 2025

MT Newswires

3 months ago

Revance Therapeutics, Crown Laboratories Extend Merger Date Amid Commercialization Dispute

0246810AI: Neutral

MT Newswires

3 months ago

Top Premarket Decliners

0246810AI: Slightly Negative

MT Newswires

5 months ago

Guggenheim Downgrades Revance Therapeutics to Neutral From Buy

0246810AI: Slightly Positive

MT Newswires

5 months ago

Needham Downgrades Revance Therapeutics to Hold From Buy

0246810AI: Slightly Negative

MT Newswires

5 months ago

Top Midday Gainers

0246810AI: Positive
Crown Laboratories, Revance Enter Merger Agreement

Exec Edge

5 months ago

Crown Laboratories, Revance Enter Merger Agreement

0246810AI: Highly Positive

Business Wire

7 months ago

Revance to Participate in Upcoming Investor Conferences

0246810AI: Neutral

Thomson Reuters StreetEvents

10 months ago

Q4 2023 Revance Therapeutics Inc Earnings Call

Associated Press Finance

a year ago

The First Bancshares: Q4 Earnings Snapshot

Associated Press Finance

a year ago

Univest: Q4 Earnings Snapshot

Thomson Reuters StreetEvents

a year ago

Q4 2023 Mercantile Bank Corp Earnings Call

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use